SPOTLIGHT: Up to 100,000 Vioxx claims expected

A federal judge in New Orleans told a gathering of attorneys that there could be as many as 100,000 Vioxx claims when all is said and done. More than 2,000 cases have been filed so far and analysts have pegged Merck's potential liability at about $18 billion. Story

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.

ATAI Life Sciences is topping off a busy year with a $125 million financing, which will push two programs through phase 2 readouts.

After more than a decade working on heart failure programs with Cytokinetics, Amgen is handing two programs back to its partner.